Association between persistent smoking after a diagnosis of heart failure and adverse health outcomes: A systematic review and meta-analysis

Abstract

INTRODUCTION Heart failure (HF) is associated with increased mortality worldwide. Adverse health outcomes in HF are commonly attributed to poor adherence to self-care, including smoking cessation. Smoking is the major modifiable risk factor for HF. Patients have been observed to continue smoking even after diagnosis with HF. Despite the possible association between persistent smoking and adverse health outcomes among HF populations, no consensus has been reached. We aimed to review the literature to determine the association between smoking status after HF diagnosis and adverse health outcomes. METHODS A systematic literature search was performed in PubMed, PsycINFO, Web of Science, and Embase. Hand searching was also performed. In total, 9 articles (n=70461) were included in the review for meta-analysis, including seven cohort studies and two cross-sectional studies. Quality was assessed using the modified version of the Newcastle-Ottawa Scale. RESULTS Approximately 16% of HF patients continued smoking after HF diagnosis. Persistent smoking increased the hazard ratio (HR) of mortality by 38.4% (HR=1.384; 95% CI: 1.139-1.681) and readmission by 44.8% (HR=1.448; 95% CI: 1.086-1.930). Our review also found that persistent smoking was associated with poor health status, ventricular tachycardia, and arterial stiffness. CONCLUSIONS This review highlights the importance of assessment for any history of smoking before and after HF diagnosis. There is a need for smoking cessation programs to be established as crucial components of care for patients with HF. More studies are needed to investigate the possible mechanisms underlying relations among smoking patterns and health consequences.

Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology

“…Smoking causes HF both indirectly, due to ischaemic heart disease, but also due to a direct effect on cardiac structure and function: in healthy individuals, greater LV mass, poorer systolic function of the left and right ventricle and also worse diastolic function as reflected by a higher E/e′ were observed in smokers compared to non‐smokers 76–80 . In a recent meta‐analysis, continued smoking after HF had been diagnosed was associated with 38% increased mortality risk and 45% increased risk of hospital readmission 81 …”

Piper sarmentosum Roxb. Attenuates Vascular Endothelial Dysfunction in Nicotine-Induced Rats

“…Nicotine is the main ingredient in tobacco smoke that causes addiction (Hecht, 2003). In addition, tobacco smoking and exposure to nicotine increase the risk of cardiovascular diseases (CVD), such as atherosclerosis, ischemic heart disease, hypertension, and stroke (Son and Lee, 2020).…”

Reinforcing Synthetic Data for Meticulous Survival Prediction of Patients Suffering From Left Ventricular Systolic Dysfunction

“…Other factors that are also important in analysing the functioning of the heart are serum creatinine, serum sodium, creatine phosphokinase (CPK), smoking behaviour, platelets etc. [16]- [21]. The aforementioned factors are vital indicator in anticipating the abnormality of the heart functioning which can be used to accurately predict the survival of the patients with the help of in-silico models [22].…”